Effect of Lisdexamfetamine Dimesylate on Parent-Rated Measures in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis

References

• Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998; 279(14): 1100–1107.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366(9481): 237–248.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol. 2007; 32(6): 631–642.
   PubMed Web of Science ®Google Scholar
• Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004; 27(2): 187–201.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Murphy KR, DuPaul GJ, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc. 2002; 8(5): 655–672.
   PubMed Web of Science ®Google Scholar
• CME Institute of Physicians Postgraduate Press, Inc. Managing ADHD in children, adolescents, and adults with comorbid anxiety. J Clin Psychiatry. 2007; 68(3): 451–462.
   PubMed Web of Science ®Google Scholar
• Schatz DB, Rostain AL. ADHD with comorbid anxiety: a review of the current literature. J Atten Disord. 2006; 10(2): 141–149.
   PubMedGoogle Scholar
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999; 56(12): 1073–1086.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002; 159(1): 36–12.
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer TJ, Newcorn JH, et al. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Bert). 2007; 190(1): 31–41.
   PubMed Web of Science ®Google Scholar
• Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999; 38(4): 402–409.
   PubMed Web of Science ®Google Scholar
• Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989; 28(6): 882–887.
   PubMed Web of Science ®Google Scholar
• Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7): 894–921.
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Crismon ML, Hughes CW, et al; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention-Deficit/Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention- deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006; 45(6): 642–657.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention- deficit/hyperactivity disorder. Pediatrics. 2001; 108(4): 1033–1044.
   PubMed Web of Science ®Google Scholar
• Stein MA, Baren M. Welcome progress in the diagnosis and treatment of ADHD in adolescence. Contemp Pediatr. 2003; 20(8): 83–110.
   Google Scholar
• Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR. Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J Manag Care Pharm. 2003; 9(5): 416–423.
   PubMedGoogle Scholar
• Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo- controlled, crossover analog classroom study. Biol Psychiatry. 2007; 62(9): 970–976.
   PubMed Web of Science ®Google Scholar
• Findling RL. Parental perceptions of the duration of effectiveness of prescription medications used to treat attention-deficit/hyperactivity disorder in children and adolescents. Poster presented at: 20th Annual US Psychiatric and Mental Health Congress; October 11–14, 2007; Orlando, FL. Poster 102.
   Google Scholar
• Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007; 29(3): 450–463.
   PubMed Web of Science ®Google Scholar
• Shojaei A, Ermer JC, Krishnan S. Lisdexamfetamine dimesylate as a treatment for ADHD: dosage formulation and pH effects. Poster presented at: the 160th Annual Meeting of the American Psychiatric Association; May 19–24, 2007; San Diego, CA. Poster NR 740.
   Google Scholar
• Jasinski DR, Krishnan S. Abuse liability of intravenous L-lysine-d- amphetamine (NRP104). Presented at: College on Problems of Drug Dependence 68th Annual Scientific Meeting; June 17–22, 2006; Scottsdale, AZ. Abstract 365.
   Google Scholar
• Findling RL, Childress AC, Krishnan S, McGough JJ. Long-term efficacy and safety of lisdexamfetamine in school-age children with attention-deficit/hyperactivity disorder. Poster presented at: 160th Annual Meeting of the American Psychiatric Association; May 19–24, 2007; San Diego, CA. Poster NR 739.
   Google Scholar
• Wigal SB, Gupta S, Guinta D, Swanson JM. Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull. 1998; 34(1): 47–53.
   PubMedGoogle Scholar
• Wolraich ML, Greenhill LL, Pelham W, et al. Randomized, controlled trial of OROS® methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001; 108(4): 883–892.
   PubMed Web of Science ®Google Scholar
• Wigal S, Swanson JM, Feifel D, et al. A double-blind, placebo- controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004; 43(11): 1406–1414.
   PubMed Web of Science ®Google Scholar
• Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR®) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002; 110(2 pt 1): 258–266.
   PubMed Web of Science ®Google Scholar
• Faraone SV. Understanding the effect size of ADHD medications: implications for clinical care, http://www.medscape.com/viewarticle/461543. Accessed November 19, 2007.
   Google Scholar
• Faraone SV. Understanding effect size: how it's measured and what it means,http://www.medscape.com/viewarticle/569729. Accessed March 18, 2008.
   Google Scholar
• Cohen J. Quantitative methods in psychology: a power primer. Psychol Bull. 1992; 112(1): 155–159.
   PubMed Web of Science ®Google Scholar
• Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004; 114(5): e541-e547.
   Web of Science ®Google Scholar
• Biederman J, Faraone SV, Monuteaux MC, Grossbard JR. How informative are parent reports of attention-deficit/hyperactivity disorder symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents' and teachers' reports. Pediatrics. 2004; 113(6): 1667–1671.
   PubMed Web of Science ®Google Scholar
• Conners CK, Sitarenios G, Parker JDA, Epstein JN. The Revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998; 26(4): 257–268.
   PubMed Web of Science ®Google Scholar
• Conners CK. Conners' Rating Scales-Revised Technical Manual. North Tonawanda, NY: Multi-Health Systems Inc; 2001.
   Google Scholar
• Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006; 67(1): 137–147.
   PubMed Web of Science ®Google Scholar
• Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005; 116(6): e777-e784.
   Web of Science ®Google Scholar
• Biederman J, Quinn D, Weiss M, et al. Efficacy and safety of Ritalin® LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs. 2003; 5(12): 833–841.
   PubMedGoogle Scholar
• Connor DF, Steingard RJ. New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic' potential. CNS Drugs. 2004; 18(14): 1011–1030.
   PubMed Web of Science ®Google Scholar
• Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001; 40(2): 147–158.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am. 2000; 9(3): 541–555, vii.
   PubMed Web of Science ®Google Scholar
• Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004; 13(suppl 1): I102–I116.
   PubMedGoogle Scholar